MedPath
NMPA Approval

Afatinib Dimaleate Tablets

国药准字H20203233

June 2, 2020

Drug Information

马来酸阿法替尼片

片剂

按C24H25ClFN5O3计 30mg

化学药品

June 2, 2020

Company Information

Applicant Company

江苏省连云港经济技术开发区

Manufacturing Company

连云港经济技术开发区庐山路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

马来酸阿法替尼片 - NMPA 批准文号 | MedPath